Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH3B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,718
Award facts
- Contract value 100% obligated
- $77,717.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 12, 2026, for the supply of Jardiance 25 mg tablets (90-count) valued at $77,717.90. This firm fixed-price contract is non-set-aside and was competitively awarded by the Defense Logistics Agency (DLA), with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 13, 2026. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, providing prescription medications across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's extensive federal contract portfolio demonstrates its capability to meet government procurement requirements for specialized pharmaceuticals, including diabetes medications, neurological treatments, pain management drugs, and other essential medical commodities. This award reflects the ongoing demand within the federal healthcare system for reliable pharmaceutical distribution services to support military and veteran healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FJH3B?
SPE2DR26FJH3B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJH3B worth?
The government has obligated $77,718 on SPE2DR26FJH3B.
Is contract SPE2DR26FJH3B an order under another contract?
Yes. SPE2DR26FJH3B is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH3B competed?
The extent of competition for SPE2DR26FJH3B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award